Contact UsBiological Products
> Biopharmaceutical Industry Insight & News > Biological Products
| Product | Clotinab | Company | ISU Abxis |
|---|---|---|---|
| Classification | Recombinant DNA product | Active Ingredient | Abciximab |
| Reference Product | Approval Date | 2007 | |
| Indication | Adjunct to Percutaneous Coronary Intervention (PCI) |
||
| Description |
The first therapeutic antibody developed in Korea and the world’s second Abciximab
Launched in Korea in 2007 and exported to twelve countries including India, Turkey, Columbia, Venezuela and etc. |
||
Korea Biomedicine Industry Association(KoBIA)
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
COPYRIGHT BY KoBIA. ALL RIGHTS RESERVED.